{"id":"W4281633450","doi":"10.33380/2305-2066-2022-11-2-180-186","title":"Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Antibody; Medicine; Virology; Immunoglobulin G; Drug; Polyclonal antibodies; Antiviral drug; Coronavirus disease 2019 (COVID-19); Immunology; Pharmacology; Infectious disease (medical specialty); Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001848201,0.000376723,0.0005322524,0.0004879213,0.0009381,0.00007584993,0.0005338836,0.00006039653,0.000226473],"category_scores_gemma":[0.0001525481,0.0003966808,0.0001285483,0.0009723922,0.0001505155,0.0001345586,0.0002902117,0.0006004108,0.00003686583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001381886,"about_ca_system_score_gemma":0.002324857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000255332,"about_ca_topic_score_gemma":0.0001607357,"domain_scores_codex":[0.9952733,0.0003630295,0.001215748,0.0007724205,0.001862198,0.0005133359],"domain_scores_gemma":[0.9982398,0.0001121782,0.0004739843,0.0007259251,0.0002538701,0.0001942319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00611056,0.0376986,0.0450583,0.001278751,0.0008860431,0.002133159,0.08169386,0.0005561958,0.7039258,0.0005656048,0.08619975,0.03389337],"study_design_scores_gemma":[0.02078324,0.0009567116,0.001579187,0.00003446008,0.00009357782,0.00004655523,0.01385666,0.0002114593,0.08542112,0.00006691956,0.8764231,0.0005270632],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933181,0.0005740409,0.0003434462,0.001034087,0.0002893082,0.002199612,0.00003311984,0.0001629585,0.002045335],"genre_scores_gemma":[0.9856507,0.00002047519,0.0004483531,0.01218382,0.0001583261,0.0004509426,0.0003669214,0.0000527837,0.0006676504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7902233,"threshold_uncertainty_score":0.9998485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07213643085207633,"score_gpt":0.3924006549297945,"score_spread":0.3202642240777182,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}